Path4 invests in the musculoskeletal industry with special interests in innovative clinical approaches that address the earlier stages of treatment and intervention. While our musculoskeletal interests are broad, we take special interest in the spine, total joints and sports medicine areas.

We strongly believe that new materials and biotechnology will change the way healthcare is delivered in the musculoskeletal industry. We closely monitor the trends of less invasive and earlier intervention treatments along with how orthobiologics will be integrated into all areas of orthopaedics. We give strong consideration to ideas that address these areas.